Dolby Laboratories, Inc.
DLB · NYSE
9/26/2025 | 9/30/2024 | 9/27/2024 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $7 | $7 | – | $8 |
| - Cash | $0 | $1 | – | $1 |
| + Debt | $0 | $0 | – | $0 |
| Enterprise Value | $7 | $7 | – | $7 |
| Revenue | $1 | – | $1 | $1 |
| % Growth | – | – | -2% | – |
| Gross Profit | $1 | – | $1 | $1 |
| % Margin | 88.1% | – | 89% | 88.3% |
| EBITDA | $0 | – | $0 | $0 |
| % Margin | 28.1% | – | 31.4% | 26.6% |
| Net Income | $0 | – | $0 | $0 |
| % Margin | 18.9% | – | 20.6% | 15.4% |
| EPS Diluted | 2.62 | – | 2.69 | 1.96 |
| % Growth | – | – | 37.2% | – |
| Operating Cash Flow | $0 | – | $0 | $0 |
| Capital Expenditures | -$0 | – | -$0 | -$0 |
| Free Cash Flow | $0 | – | $0 | $0 |